Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply
N Engl J Med
.
2023 Jul 20;389(3):285-286.
doi: 10.1056/NEJMc2306683.
Authors
Ronen Arbel
1
,
Ruslan Sergienko
2
,
Doron Netzer
3
,
Ariel Hammerman
4
,
Michael Friger
2
,
Alon Peretz
3
,
Talish Razi
3
,
Hadar Duskin-Bitan
3
,
Shlomit Yaron
3
Affiliations
1
Clalit Health Services, Tel Aviv, Israel ronenarb@clalit.org.il.
2
Ben-Gurion University of the Negev, Beersheba, Israel.
3
Clalit Health Services, Tel Aviv, Israel.
4
Medison Pharma, Petah Tikva, Israel.
PMID:
37470347
DOI:
10.1056/NEJMc2306683
No abstract available
Publication types
Letter
Comment
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Substances
BNT162 Vaccine
COVID-19 Vaccines